Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

News · April 04, 2022

Risk for Acute MI Not Increased With Two-Dose HepB-CpG Vaccine

Noninferiority study shows no increased risk for acute MI with two-dose HepB-CpG vaccine versus three-dose HepB-alum vaccine



Further Reading